Baynes Roy D. bought TVTX
April 14, 2026 · Form 4 insider transaction
Baynes Roy D. bought 6,750 shares of Travere Therapeutics, Inc. at $17.11 per share, a transaction worth $115.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,750
Price
$17.11
Total value
$115.5K
InsiderBaynes Roy D.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after70,250
OwnershipDirect
10b5-1 planNo
AmendedNo